AKT1 and posterior cortical atrophy: A‐443654 is an indazopyridine inhibitor that reversibly binds to the ATP‐binding site on AKT, leading to the inhibition of glycogen synthesis kinase phosphorylation in PCa cells, promotion of glycogen synthesis, and suppression of PCa cells growth [11].